Sulfadiazine
FDA Approved
Description
Sulfadiazine is a sulfonamide antibiotic used to treat various bacterial infections and, in combination with pyrimethamine, toxoplasmosis. It inhibits the synthesis of dihydrofolic acid in susceptible organisms, thereby preventing their growth.
Indications & Therapeutic Use
Toxoplasmosis, Bacterial Infections
Linked Diseases:
congenital toxoplasmosis
D014125
Global Availability (1 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Sulfadiazine
| Generic Name | Sulfadiazine |
| Active Ingredient | Sulfadiazine |
| Drug Class | Toxoplasmosis |
| Dosage Forms | Tablet |
| Medical Code | J01EC02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Reg. Status | FDA Approved |
| Countries | 1 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations2 Validated Nodes